Optometrist · Austin, TX
NPI
1265407084
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
901 Mopac Expressway South, Building 4 Suite 350
Austin, TX, 78746
Phone (512) 347-0255
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
886 services
Medicare patients, 2024
423
Average age 74
Drug cost, 2024
$1.7M
1,445 prescriptions
Company payments, 2025
$198K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Derek N Cunningham was code 92012 (ophthalmological e&m), 365 times for 213 patients. In total Derek N Cunningham billed 886 services in 15 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 365 | 213 | $61.90 | $23K |
| 92014 Ophthalmological E&M | Office | 230 | 218 | $84.80 | $20K |
| 92134 Computerized Ophthalmic Imaging | Office | 60 | 60 | $31.04 | $1,862 |
| 65778 Eye | Office | 47 | 27 | $858.91 | $40K |
| 92004 Ophthalmological E&M | Office | 42 | 42 | $95.91 | $4,028 |
| 68761 Eye | Office | 39 | 36 | $163.49 | $6,376 |
| 92133 Computerized Ophthalmic Imaging | Office | 36 | 35 | $26.07 | $939 |
| 92083 Vision, Hearing, and Speech Services | Office | 32 | 30 | $38.24 | $1,224 |
| 92250 Angiography | Office | 28 | 26 | $22.77 | $638 |
By year: 2022 $104K for 846 services; 2023 $111K for 912 services; 2024 $98K for 886 services.
Medicare prescription drug claims, 2024
In 2024, the drug Derek N Cunningham prescribed most often to Medicare patients was Xiidra (Lifitegrast), with 528 prescriptions and refills. In total Derek N Cunningham wrote 1,445 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | 528 | 1,149 | 227 | $733K |
| Latanoprost Generic | 190 | 382 | 57 | $1,945 |
| Lotemax Sm Loteprednol Etabonate | 137 | 139 | 99 | $34K |
| Miebo Perfluorohexyloctane/Pf | 100 | 118 | 23 | $84K |
| Restasis Cyclosporine | 84 | 180 | 41 | $106K |
| Cequa Cyclosporine | 60 | 103 | 23 | $56K |
| Vevye Cyclosporine | 37 | 47 | 11 | $29K |
| Vyzulta Latanoprostene Bunod | 36 | 58 | 16 | $16K |
| Zylet Tobramycin/Lotepred Etab | 33 | 36 | 32 | $12K |
| Eysuvis Loteprednol Etabonate | 28 | 28 | 24 | $13K |
| Prolensa Bromfenac Sodium | 28 | 32 | 22 | $10K |
| Simbrinza Brinzolamide/Brimonidine Tart | 22 | 35 | Under 11 | $5,629 |
| Brimonidine Tartrate Generic | 15 | 17 | Under 11 | $2,861 |
| Combigan Brimonidine Tartrate/Timolol | 13 | 17 | Under 11 | $3,360 |
| Tyrvaya Varenicline Tartrate | 13 | 15 | Under 11 | $9,047 |
Brand drugs: 1,292 claims; generic drugs: 153 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Derek N Cunningham $198K ($198K in general payments such as food, travel and fees) from 13 companies. The largest payer was Bausch & Lomb Americas Inc. with $79K.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 154 | $79K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 112 | $69K |
| Alcon Vision LLC ALC | 87 | $45K |
| Alcon Research LLC ALC | 1 | $2,700 |
| Sight Sciences, Inc. SGHT | 3 | $904 |
| Harrow Eye, LLC | 11 | $529 |
| Tarsus Pharmaceuticals, Inc. TARS | 14 | $173 |
| ANI Pharmaceuticals, Inc. ANIP | 8 | $143 |
| Abbvie Inc. ABBV | 2 | $61.75 |
| RxSight Inc RXST | 2 | $51.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.